Attendees

The Respiratory Innovation Summit would like to thank everyone who attended.

#

4Dx
Andreas Fouras, CEO
Neeraj Vij, PhD, SVP, Clinical Development

A

Acceleron Pharma
Andrew Leger, PhD, Director, Business Development

AIRx Health
Marlon Castillo, COO
Vijay Rajasekhar, MD, CEO

Allergy & Asthma Network
Tonya Winders, President & CEO

Altavant Sciences
LynBaranowski, COO

American Thoracic Society
Bridget Burns, Senior PAR Specialist
Lara Endreszl, Assistant Manager, Corporate Alliances
Dayna Howell, Project Coordinator, Corporate Alliances
Vlada O'Hara, Manager, Corporate Alliances
Polly Parsons, President
Courtney White, Director, Patient Outreach

Amgen
Jonathan Phillips, Principal Scientist

Apple Tree Partners / Gala Therapeutics
Jonathan Waldstreicher, MD

ARDS Foundation
Susan East, Community Outreach Coordinator

ArtiQ
Marko Topalovic, PhD, CEO

AstraZeneca
Alexandra Arikoglu, Communications Director, Respiratory & Autoimmunity

Avisa
David Joseph, President & CEO

B

Battelle
Lewis Vann, PhD, Director, Business Development Efficacy & Toxicology

Bayer
Alan Cohen, MD, Global Clinical Leader
Lisa Mendoza, PhD, Associate Director, Open Innovation

Bellerophon Therapeutics
Parag Shah, Executive Assistant
Fabian Tenenbaum, CEO

Boehringer Ingelheim Pharmaceuticals
Craig Conoscenti, MD, Medical Expert, Interstitial Lung Disease

C

CDRD
Paul Cassar, PhD, Scientist

Celgene Corporation
Theodore Reiss, MD, Corporate VP, Head, I&I Clinical R&D

CF PharmTech
Bill Liang, PhD, CEO

Child Foundation
Gregory Porta, Director & Founder

Colorado University
Melanie Königshoff, MD, PhD

Coridea
Mark Gelfand, Managing Partner

Cystic Fibrosis Foundation
John Sheridan, Director, Research

D

David Geffen School of Medicine at UCLA
Jonathan Goldin, Professor

Duke University Health System
Momen Wahidi, MD

E

Eldec Pharmaceuticals
Robert Tarran, PhD, Professor

Electromed
Alan Mueller, Director, Marketing

Ena Therapeutics
Christophe Demaison, CEO

Euclidean Diagnostics
Simon Walsh, Founder

F

Fisher & Paykel Healthcare
Jason Kirkness, Director, Clinical Affairs

Fluidda
Jan De Backer, PhD, CEO
Elizabeth Dorsey, Client Manager

Foundation for Sarcoidosis Research
Ginger Spitzer, Executive Director

G

Gala Therapeutics
Michelle Machuca, Senior Director, Market Access
Deb Sheffield, VP, Regulatory & Quality
Kevin Taylor, VP, R&D

Genentech
Ahmar Iqbal, Group Medical Director
Benjamin Kramer, MD, VP, Immunology & Ophthalmology, US Medical Affairs
Daniel Lee, Senior Medical Science Director

Gilead Sciences
Tim Watkins, MD, Director, Clinical Research, Respiratory & Inflammation Therapeutics

GlaxoSmithKline
Scott Caveney, MD, PhD, Medical Director
Courtney Crim, MD, Group Director
Mark Forshag, MD, Medical Director

GlycoMira Therapeutics
Abby Pulsipher, PhD, Director, Respiratory R&D

H

Harvard Medical School / Brigham and Women's Hospital
Bruce Levy, MD, Parker B. Francis Professor / PCCM Division Chief
George Washko, Associate Professor of Medicine / Pulmonary & Critical Care Medicine

HCmed Innovations
Yi-Ying Chen, Business Development Manager
Jason Cheng, Founder & CEO

Healthvest
Eric Nelson, PhD, Business Development Consultant

Hermansky-Pudlak Syndrome Network
Ashley Appell
Donna Appell, Executive Director

I

Indalo Therapeutics
Karl Kossen, SVP Translational Science

Inscope Medical Solutions
Margaret Galloway, CEO

Insmed Incorporated
Mosha Deng, Corporate Development

ITR Laboratories Canada
Assad Aslam, Product Specialist, Aerosol Sciences & Inhalation Toxicology

J

Johns Hopkins University School of Medicine
Lonny Yarmus, Clinical Chief, Division of Pulmonary & Critical Care, Johns Hopkins University

L

Liberate Medical
Angus McLachlan, PhD, CEO

Liquidia Technologies
Jason Adair, VP, Corporate Development & Strategy

Longitude Capital
Greg Grunberg, MD, Managing Director

Lung Center Ulm
Holger Woehrle, Medical Director

Lung Transplant Foundation
Jeffrey Goldstein, CEO

Lungpacer Medical
Doug Evans, CEO

M

Masimo
Tao Levy, EVP, Business Development

Magnolia Therapeutics
Wade Lange, COO

Massachusetts General Hospital, Harvard Medical School
Erik Folch, Chief, Complex Chest Disease Center

MGC Diagnostics
Todd Austin, CEO

Morair Medtech
Robert Barry, CEO

MST
Mattiennevan der Kamp, Researcher

N

National Jewish Health
Gregory Cosgrove, MD, Pulmonologist
Irina Petrache, MD, Chief & Professor, Pulmonary, Critical Care & Sleep Medicine

NHLBI
Mike Pieck, Small Business Program Coordinator

NIH
Neil Aggarwal, MD, Branch Chief, Division of Lung Diseases
Antonello Puntureri, MD, PhD, Program Director, COPD

Nocion Therapeutics
Rick Batycky, PhD, CEO

Nuvaira
Jim Pavliska, VP of Clinical Affairs
Lisa Rogan, SVP, Global Market Development
Dennis Wahr, MD, CEO

O

Oberland Capital
Cecilia Gonzalo, Partner

OCR  Yale University
Milica Vukmirovic, Blavatnik Fellow

Olympus Respiratory America
Lisa Lauer, Executive Director
Greg Sessler, President & CEO

Optellum
Vaclav Potesil, PhD, Co-founder, CEO

Oregon Health & Science University
Molly Osborne, MD, PhD, ATS Board Member

P

Parion Sciences
Paul Boucher, President & CEO

Pearl Therapeutics -  AstraZeneca
Colin Reisner, MD, CEO & Head, Respiratory Global Medicines

Peytant Solutions, Inc
John Schorgl, CEO

PCD Foundation
Carey Kauffman, Patient Representative

Pfizer
Paul Wacnik, R&D

Pharmaceutical Advantage Partners
Stephen Beckman, Principal

Pharmosa Biopharm
Pei Kan, PhD, President

Pieris Pharmaceuticals
Ahmed Mousa, Vice President & General Counsel
Allan Reine, CFO

Piper Jaffray
Charles Hamilton, Director
Ryan Kaeding, Director
Michael Ragan, Director
James White, Director

Pliant Therapeutics
Bernard Coulie, MD, PhD, CEO
Eduard Gorina, MD, VP, Clinical Development
Eric Lefebvre, MD, CMO

Propeller Health
Chris Hogg, Chief Commercial Officer

ProterixBio
Michael Miller, CEO

Pulmocide
Peter Strong, PhD, CSO

Pulmonary Fibrosis Foundation
Pauline Bianchi, VP, Research & Development
Jennifer Mefford, Senior Director, Corporate Relations

Pulmonx
Beran Rose, VP, Marketing & Business Development

R

Regeneron
Marcella Ruddy, VP, Clinical Development Respiratory & Inflammation

ResMed
Jeff Armitstead, VP, Clinical Science & Innovation
Priyanshu Gupta

Respivant
Ahmet Tutuncu, EVP, Clinical & Regulatory

Roche/Genentech
Enza DiModugno, Business Development

Rutgers Robert Wood Johnson Medical School

Jag Sunderram, Professor of Medicine

S

Sandbox Industries
Kwasi Kyei, Investor

Sanofi Genzyme
Lucia Gomez, Scientific Advisor
David Gossage, MD, Director Medical Affairs
Yimin Qin, Sr. Medical Director
Paul Rowe, Head, Respiratory

Santé Ventures
James Eadie, MD, Partner

Savara
John Lord, PhD, Senior Vice President and Head of R&D

Scleroderma Foundation
Kerri Connolly, National Director of Programs & Services

Scripps Health
Angela Wang, MD

Spire Health
Jonathan Palley, CEO

Spirosure
Ryan Leard, CTO & COO

Surveyor Capital
Isai Peimer, Senior Analyst

T

Temasek
Cayce Denton, Director

The University of Arizona Colleges of Pharmacy & Medicine
Heidi Mansour, PhD, Associate Professor

Theravance Biopharma
Glenn Crater, MD, VP, Clinical Development & Medical Affairs
Karmon Johnson, Medical Director, Respiratory
Srikanth Pendyala, MD, Director, Clinical Development

Third Pole
Elizabeth Holmberg, VP, Finance & Corporate Development

Thorasys Thoracic Medical Systems
Yvan Beaudoin, President

Three Lakes Partners
Kenneth Bahk, PhD, CEO

Tulane University
Jay Kolls, Professor

U

UCSD
Richard Rose, MD, Adjunct Professor

University of Arizona
Joe G.N. Garcia, MD, Dr. Merlin K. DuVal Professor of Medicine

University of Alabama at Birmingham
Surya Bhatt, MD, Associate Professor

University of Illinois at Chicago
Dean Schraufnagel, MD, Professor

University of Michigan
Bethany Moore, Professor
Eric White, MD, Professor of Internal Medicine, Division of Pulmonary & Critical Care Medicine

University of Vermont Medical Center
Matt Kinsey, MD, Director, Interventional Pulmonary

V

Veran Medical Technologies
TJ Meyer, Executive Director of Global Marketing
Jason Pesterfield, CEO

Vertex Pharmaceuticals
Cecile Le Camus, MD, Senior Director

VIDA
Susan Wood, PhD, President & CEO